Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) EV to CFO (2014 - 2026)

Scynexis' (SCYX) quarterly EV to CFO came in at 4.98 in Q2 2026, down 19.99% on a YoY basis from 6.23 in Q2 2025, and down 16.34% quarter-over-quarter from 5.96 in Q1 2026.

Analysis

Scynexis (SCYX) EV to CFO (2014 - 2026) Analysis & Trends

Scynexis (SCYX) has reported EV to CFO for 13 consecutive years, with 4.98 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, EV to CFO fell 19.99% year-over-year to 4.98; the trailing twelve-month figure through Jun 2026 stood at 5.58 (up 187.76% YoY), and the FY2025 full-year result was 2.37, up 9378.11% from the prior year.
  • EV to CFO retreated to 4.98 in Q2 2026 per SCYX's latest filing, from 5.96 in the prior quarter.
  • Across five years, EV to CFO topped out at 16.98 in Q1 2024 and bottomed at 68.7 in Q3 2024.
  • Historically, EV to CFO has averaged 1.78 across 5 years, with a median of 0.37 in 2022.
  • The widest YoY moves for EV to CFO: up 970.31% in 2024, down 2032.6% in 2024.
  • Over 5 years, EV to CFO stood at 0.31 in 2022, then slumped by 1457.55% to 4.18 in 2023, then surged by 101.45% to 0.06 in 2024, then plunged by 1222.87% to 0.68 in 2025, then soared by 834.03% to 4.98 in 2026.
  • According to Business Quant data, EV to CFO over the past three periods registered 4.98, 5.96, and 0.68 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Scynexis 58.41 Mn -56.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.98
Mar 31, 2026 5.96
Dec 31, 2025 -0.68
Sep 30, 2025 3.29
Jun 30, 2025 6.23
Mar 31, 2025 5.41
Dec 31, 2024 0.06
Sep 30, 2024 -68.70
Jun 30, 2024 3.11
Mar 31, 2024 16.98
Dec 31, 2023 -4.18
Sep 30, 2023 -3.22
Jun 30, 2023 0.29
Mar 31, 2023 -3.20
Dec 31, 2022 0.31
Sep 30, 2022 0.42
Jun 30, 2022 2.06
Mar 31, 2022 -1.19
Dec 31, 2021 -2.77
Sep 30, 2021 -1.60